[HTML][HTML] Challenges to vaccination against SARS-CoV-2 in patients with immune-mediated diseases
Aberrant deployment of the immune response is a hallmark pathogenic feature of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) …
[HTML][HTML] COVID-19 vaccine-associated myocarditis: analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature
Abstract Background Myocarditis secondary to Coronavirus Disease 2019 (COVID-19)
vaccination has been reported in the literature. Objective This study aimed to characterize …
vaccination has been reported in the literature. Objective This study aimed to characterize …
[HTML][HTML] Benefits and harms of COVID-19 vaccines in cardiovascular disease: a comprehensive review
CY Chen, TC Su - Journal of Lipid and Atherosclerosis, 2023 - ncbi.nlm.nih.gov
Patients with a history of cardiovascular disease (CVD) who contract coronavirus disease
2019 (COVID-19) tend to have a worse prognosis and more severe cardiovascular side …
2019 (COVID-19) tend to have a worse prognosis and more severe cardiovascular side …
[HTML][HTML] SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
A Suvorov, S Loginova, G Leontieva, T Gupalova… - Vaccines, 2023 - mdpi.com
The declaration of the conclusion of the COVID-19 pandemic notwithstanding, coronavirus
remains prevalent in circulation, and the potential emergence of novel variants of concern …
remains prevalent in circulation, and the potential emergence of novel variants of concern …
[HTML][HTML] Case report: Myocarditis following COVID-19 protein subunit vaccination
Y Dong, X Liu, C Yang, Q Qi, W Shi, Y Li… - Frontiers in …, 2022 - frontiersin.org
We report findings in a 34-year-old female patient who presented with fulminant myocarditis
8 days after receiving the first dose of the ZF2001 RBD-subunit vaccine against coronavirus …
8 days after receiving the first dose of the ZF2001 RBD-subunit vaccine against coronavirus …
Modified mRNA-based vaccines against coronavirus disease 2019
AYL Wang - Cell transplantation, 2022 - journals.sagepub.com
The pandemic of coronavirus disease 2019 (COVID-19) continuously causes deaths
worldwide, representing a considerable challenge to health care and economic systems …
worldwide, representing a considerable challenge to health care and economic systems …
[HTML][HTML] Myocarditis following COVID-19 vaccination: Cardiac imaging findings in 118 studies
We reviewed the reported imaging findings of myocarditis in the literature following COVID-
19 vaccination on cardiac imaging by a literature search in online databases, including …
19 vaccination on cardiac imaging by a literature search in online databases, including …
Giant cell myocarditis after first dose of BNT162b2–a case report
VG Hirsch, S Schallhorn, C Zwadlo… - European Journal of …, 2022 - Wiley Online Library
Herein we report the case of a young man, admitted to the Department of Cardiology and
Angiology at Hannover Medical School with shortness of breath and elevated troponin. Few …
Angiology at Hannover Medical School with shortness of breath and elevated troponin. Few …
[HTML][HTML] Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
PBT Saputra, RB Kurniawan, D Trilistyoati… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
Vaccination is significant to control, mitigate, and recover from the destructive effects of
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …
[HTML][HTML] Safety and immunogenicity of the BBIBP-CorV vaccine in adolescents aged 12 to 17 years in the Thai population: an Immunobridging study
K Tawinprai, T Siripongboonsitti, T Porntharukchareon… - Vaccines, 2022 - mdpi.com
Adolescents can develop a severe form of Coronavirus disease 2019 (COVID-19),
especially with underlying comorbidities. No study has examined the efficacy or …
especially with underlying comorbidities. No study has examined the efficacy or …